Login / Signup

Targeting Secondary and Tertiary Resistance to BRAF Inhibition in BRAF V600E-Mutated Metastatic Colorectal Cancer.

Dilara AkhoundovaHeike PietgeSaskia HussungMichael KiesslingChristian BritschgiMartin ZocheMarkus RechsteinerAchim WeberRalph M Fritsch
Published in: JCO precision oncology (2022)
Keyphrases
  • metastatic colorectal cancer
  • cancer therapy
  • drug delivery